Remifentanil pharmacokinetics in obese versus lean patients

Anesthesiology

Volumn 89, Issue 3, 1998, Pages 562-573

  Egan, Talmage D ^d   Huizinga, Bernou ^e   Gupta, Samir K ^a   Jaarsma, Rudy L ^e   Sperry, Richard J ^e   Yee, James B ^b   Muir, Keith T ^c  

^a Division of Clinical Pharmacology   (United States)

^b Alta View Hospital   (United States)

^c GLAXOSMITHKLINE   (United States)

^d UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^e NONE

Author keywords

Body weight; Obesity; Opioids; Pharmacokinetics; Remifentanil

Indexed keywords

MIDAZOLAM; OPIATE; REMIFENTANIL; THIOPENTAL;

ADULT; ANESTHESIA INDUCTION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARTMENT MODEL; COMPUTER SIMULATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; ELECTIVE SURGERY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEAN BODY WEIGHT; MALE; OBESITY; PHARMACOKINETICS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANALGESICS, OPIOID; BODY WEIGHT; COMPUTER SIMULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; PIPERIDINES;

EID: 0031696064     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199809000-00004     Document Type: Article

References (31)

1. Egan TD: Remifentanil pharmacokinetics and pharmacodynamics: A preliminary appraisal. Clin Pharmacokinet 1995; 29:80-94
2. Westmorland CL, Hoke JF, Sebel PS, Hug CC, Muir KT: Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. ANESTHESIOLOGY 1993; 79:893-903
3. Glass PSA, Hardman D, Kamiyama Y, Quill TJ, Marton G, Donn KH, Grosse CM, Hermann D: Preliminary pharmacokinetics and pharmacodynamics of an ultra-short acting opioid: Remifentanil (GI87084B). Anesth Analg 1993; 77:1031-40
4. Egan TD, Lemmens HJM, Fiset P, Hermann DJ, Muir KT, Stanski DR, Shafer SL: The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. ANESTHESIOLOGY 1993; 79:881-92
5. Egan TD, Minto CF, Hermann DJ, Barr J, Muir KT, Shafer SL: Remifentanil versus alfentanil: Comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers. ANESTHESIOLOGY 1996; 4:821-33
6. Shafer SL, Varvel JR: Pharmacokinetics, pharmacodynamics and rational opioid selection. ANESTHESIOLOGY 1991; 74:53-63
7. Hughes MA, Glass PSA, Jacobs JR: Context-sensitive half-times in multicompartment pharmacokinetic models for intravenous anesthetic drugs. ANESTHESIOLOGY 1991; 76:334-41
8. Hoke JF, Shlugman D, Dershwitz M, Michalowski P, Malthouse-Dufore S, Connors PM, Martel D, Rosow CE, Muir KT, Rubin N, Glass PS: Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers. ANESTHESIOLOGY 1997; 87(3):533-41
9. Dershwitz M, Hoke JF, Rosow CE, Michalowski P, Connors PM, Muir KT, Dienstag JL: Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease. ANESTHESIOLOGY 1996; 84:812-20
10. Egan TD, Billard V, Barr J, Gambus P, Hermann DJ, Muir KT, Shafer SL: Gender has no effect on the pharmacokinetics or pharmacodynamics of remifentanil [abstract]. ANESTHESIOLOGY 1995; 83:A325
11. Minto CF, Schnider TW, Egan TD, Youngs E, Lemmens HJM, Gambus PL, Billard V, Hoke F, Moore KHP, Hermann DJ, Muir KT, Mandema JW, Shafer SL: The influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model Development. ANESTHESIOLOGY 1997; 86:10-23
12. Abernethy DR, Greenblatt DJ: Pharmacokinetics of drugs in obesity. Clin Pharmacokinet 1982; 7:108-24
13. Egan TD, Wong KC: Predicting difficult laryngoscopy for tracheal intubation - An approach to airway assessment. Acta Anaesthesiol Sin 1993; 31:165-78
14. Grosse CM, Davis IM, Arrendal RF, Jersey J, Amin J: Determination of remifentanil in human blood by liquid-liquid extraction and capillary GC-HRMS-SIM using a deuterated internal standard. J Pharm Biomed Anal 1994; 12:195-203
15. Wagner JG: Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data. J Pharmacokinet Biopharm 1976; 4:443-67
16. Sheiner LB: The population approach to pharmacokinetic data analysis - rationale and standard data analysis methods. Drug Metab Rev 1984; 15:153-71
17. Maitre PO, Buhrer M, Thomson D, Stanski DR: A three-step approach combining Bayesian regression and NONMEM population analysis: Application to midazolam. J Pharmacokin Biopharm 1991; 19:377-84
18. Morgan DJ, Bray KM: Lean body mass as a predictor of drug dosage - Implications for drug therapy. Clin Pharmacokinet 1994; 26: 292-307
19. Youngs EJ, Shafer SL: Pharmacokinetic parameters relevant to recovery from opioids. ANESTHESIOLOGY 1994; 81:833-42
20. Roubenoff R, Kehayias JJ: The meaning and measurement of lean body mass. Nutr Rev 1991; 49:163-75
21. Minto CF, Schnider TW, Shafer SL: Pharmacokinetics and pharmacodynamics of remifentanil: II. Model application. ANESTHESIOLOGY 1997; 86:24-33
22. Glass PSA: Remifentanil: A new opioid. J Clin Anesth 1995; 7:558-63
23. Egan TD, Muir KT, Stanski DR, Shafer SL. The EEG versus clinical measures of opioid potency: Defining the EEG-clinical potency fingerprint with application to remifentanil [abstract]. ANESTHESIOLOOY 1996; 85:A349
24. Wulfsohn NL: Halothane dosage based on lean body mass. Br J Anaesth 1969; 41:522-6
25. Wulfsohn NL, Joshi CW: Thiopentone dosage on lean body mass. Br J Anaesth 1969; 41:516-21
26. Beemer GH, Bjorksten AR, Crankshaw DP: Effect of body build on the clearance of atracurium: Implication for drug dosing. Anesth Analg 1993; 76:1296-303
27. Schwartz AE, Matteo RS, Ornstein E, Young WL, Myers KJ: Pharmacokinetics of sufentanil in obese patients. Anesth Analg 1991; 73:790-3
28. Maitre PO, Vozeh S, Heykants J, Thomson DA, Stanski DR: Population pharmacokinetics of alfentanil: The average dose-plasma concentration relationship and interindividual variability in patients. ANESTHESIOLOGY 1987; 66:3-12
29. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL: Increasing prevalence of overweight among US adults, The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 1994; 272:205-11
30. Williamson DF: Descriptive epidemiology of body weight and weight change in US adults. Ann Intern Med 1993; 119:646-9
31. Egan TD: Intravenous drug delivery systems: Toward an intravenous vaporizer. J Clin Anesth 1996; 8:8S-14S